Article: NAMPT Deficiency in Mouse Liver Cells Shows Minimal Impact on NAD+ and Mitochondrial Health: Preclinical Findings

PrevNext
Healthy Aging & Longevity Metabolic Health Orphan Disease Preclinical

NAMPT Deficiency in Mouse Liver Cells Shows Minimal Impact on NAD+ and Mitochondrial Health: Preclinical Findings

Synopsis

Supplementation with NAD+ precursors such as nicotinamide riboside (NR) has been shown to improve mitochondrial function and prevent liver fat accumulation in high-fat diet (HFD)-fed rodents. However, the role of the NAD+-producing enzyme NAMPT in liver metabolism is less clear. Researchers created mice lacking NAMPT specifically in liver cells (HNKO), which reduced liver NAD+ by 50%. After 20 weeks on a high-fat diet with or without NR, NR raised NAD+ levels but did not affect fat mass, glucose tolerance, or most mitochondrial functions in HNKO mice. Mitochondrial NAD+ dropped only 20%, and HNKO mice compensated by increasing de novo NAD+ synthesis. Overall, loss of NAMPT in hepatocytes had only mild effects on mitochondrial function.

Journal

Journal of Biological Chemistry

Share

Read more

NAD-Related Compounds Affect Immune Cell Growth and Inflammatory Response: Preclinical Findings

Petin K, Weiss R, Muller G, Garten A, Grahnert A, Sack U, Haushildt S Over the past few years the NAD-related compounds nicotinamide (NAM), nicotinamide riboside (NR) and 1-methylnicotinamide ...

Read more
Inflammation

Maternal Nicotinamide Riboside Supplementation Supports Postpartum Recovery and Offspring Brain Health: Preclinical Findings

Synopsis Metabolic stress can disrupt the balance of NAD+ molecules in the body. Nicotinamide riboside (NR) helps restore NAD+ levels and protect against such stress. This study tested whether NAD...

Read more